Fact-checked by Grok 2 weeks ago

External ventricular drain

An external ventricular drain (EVD), also known as an external ventricular catheter, is a temporary neurosurgical device consisting of a small tube inserted into the brain's ventricles to drain excess (CSF), continuously monitor (ICP), and for (CSF) sampling and analysis. It serves as a life-saving in cases of acute or elevated ICP, conditions often arising from (SAH), (TBI), (IVH), infections, brain tumors, or shunt malfunctions. EVD insertion is typically performed emergently by a neurosurgeon, often at the bedside in the or operating room, using a freehand technique at Kocher's point on the frontal skull (approximately 12 cm from the and 3 cm lateral to the midline) to access the lateral ventricle. The procedure involves creating a burr hole in the skull, advancing a (usually no more than 7 cm deep toward the foramen of Monro), tunneling it subcutaneously, and connecting it to an external drainage system with a leveled to the foramen of Monro for accurate measurement. Management strategies vary by underlying condition: continuous drainage (e.g., 10 mL/hour) is preferred in SAH and TBI to minimize complications like clogging, while intermittent drainage may be used cautiously; CSF output is monitored (typically 100–300 mL/day), and the device is weaned gradually once stabilizes to reduce dependency on permanent shunts. Despite its efficacy, EVD placement carries risks, including (0–27% incidence, rising with duration and CSF sampling), hemorrhage along the tract (up to 12%), mechanical obstruction by blood clots or tissue, misplacement, and overdrainage leading to subdural hematomas. Operating room insertion and strict sterile protocols, such as antibiotic-impregnated catheters, help mitigate rates (e.g., 7.7% in OR vs. 13% in emergency settings). The device is removed once CSF dynamics normalize, often after several days to weeks, with complications potentially prolonging hospital stays and impacting prognosis.

Overview

Definition and Purpose

An external ventricular drain (EVD) is a temporary neurosurgical device designed to manage intracranial conditions by facilitating the drainage of (CSF) from the brain's ventricles. It consists of a thin, flexible inserted into one of the brain's ventricles, typically the lateral ventricle, which is connected via tubing to an external collection system, such as a drainage bag or chamber. This setup often incorporates an (ICP) transducer, zeroed to the level of the foramen of Monro, to enable continuous monitoring of ICP alongside fluid diversion. The physiological purpose of an EVD is to reduce elevated , which can exceed 20 mmHg in critical scenarios, by draining excess CSF or blood, thereby mitigating the risk of and supporting cerebral . Additionally, it permits diagnostic CSF sampling for analysis and therapeutic instillation of medications, such as tissue plasminogen activator, directly into the ventricular space. This multifunctional role makes the EVD essential in acute settings, including the management of . External ventricular drainage was first described in 1744 by Claude-Nicolas Le Cat as a device for repeated drainage in the treatment of congenital , with continuous external drainage developing in the early 20th century building on earlier pioneering efforts in ventricular access from the 18th and 19th centuries. In contrast to permanent internal shunts, such as ventriculoperitoneal devices that redirect CSF to the without external access, EVDs remain and adjustable, allowing precise control over drainage rates and real-time ICP assessment until the underlying issue resolves.

Indications and Contraindications

External ventricular drains (EVDs) are primarily indicated for the management of acute resulting from conditions such as (SAH), (TBI), (IVH), , or post-tumor resection. They are also used for therapeutic (ICP) monitoring in comatose patients, particularly those with severe TBI and scores of 3-8 accompanied by abnormal computed tomography findings. EVD placement is often lifesaving in emergency scenarios involving rapid ICP elevation, such as acute obstructive following SAH or large-volume (ICH) with IVH and neurological deterioration, where it facilitates immediate (CSF) diversion to alleviate pressure. In contrast, elective use occurs for controlled CSF diversion, such as intraoperative relaxation during procedures for posterior tumors or to manage from shunt malfunction. Contraindications to EVD insertion include uncorrectable , such as an international normalized ratio greater than 1.5 or concurrent use of anticoagulants or antiplatelet agents without reversal, due to heightened risk of hemorrhagic complications. Relative contraindications encompass significant on imaging, which may indicate herniation risk or inaccurate pressure readings, as well as superficial infections at the proposed insertion site or systemic infections that could predispose to . These indications and contraindications are supported by guidelines from neurosurgical and neurocritical care societies, which emphasize EVD use for exceeding 20 mmHg unresponsive to medical therapy, particularly in severe TBI where continuous CSF drainage improves control (Level III evidence). The /American Stroke Association guidelines further recommend EVD for in ICH/IVH with decreased consciousness to reduce mortality.

Placement Procedure

Preoperative Preparation

Preoperative preparation for external ventricular drain (EVD) insertion begins with a thorough patient assessment to evaluate suitability and minimize risks. This includes a detailed neurological examination to document baseline status, such as Glasgow Coma Scale (GCS) score and focal deficits, which helps guide urgency in cases of elevated intracranial pressure (ICP). Coagulation studies, including prothrombin time (PT), international normalized ratio (INR), and partial thromboplastin time (PTT), are essential to identify bleeding risks, with an acceptable INR range typically 1.2–1.6 for adults. Preoperative imaging via computed tomography (CT) or magnetic resonance imaging (MRI) is reviewed to confirm ventricular enlargement, assess midline shift, and identify optimal insertion sites, ensuring procedural precision. Risk mitigation strategies focus on correcting coagulopathies and preventing infections. Anticoagulants such as should be discontinued 5 days prior to elective insertion to allow INR normalization, while urgent cases may require reversal with or (PCC) to achieve therapeutic levels promptly. Prophylactic antibiotics, such as , are administered as a single dose approximately 30 minutes before incision to reduce infection risk, particularly in operating room settings. is obtained from the patient or surrogate, detailing procedure benefits and potential complications, even in emergencies where verbal consent may suffice initially. Patient positioning and site preparation follow standard protocols to facilitate safe access. The patient is placed with the head elevated 30 degrees in a neutral position to optimize venous drainage and reduce , while the insertion site (typically Kocher's point) is shaved minimally and prepped with an solution like or using sterile technique. Equipment setup involves selecting an appropriate , such as polyurethane for monitoring or antibiotic-impregnated variants (e.g., with and rifampin) to lower rates, alongside ensuring availability of guidance tools like or neuronavigation if image-guided placement is planned.

Insertion Technique

The insertion of an external ventricular drain (EVD) typically occurs at Kocher's point on the non-dominant , located approximately 2-3 cm lateral to the midline and 1-2 cm anterior to the , or equivalently 11 cm posterior to the along the midline and then 2.5-3 cm lateral, to target the frontal horn of the ipsilateral lateral ventricle. This freehand approach relies on surface landmarks, such as the midpupillary line and tragus, with the patient's head positioned and elevated 30-45 degrees to facilitate access and minimize venous bleeding. The procedure begins with and mild administered at the entry , following sterile preparation that may include prophylactic antibiotics as outlined in preoperative protocols. A 3-4 cm linear skin incision is made at Kocher's point, followed by through the galea and scraping of the to expose the bone. A burr hole is then drilled using a twist drill, Hudson brace, or craniotome with saline irrigation to penetrate the cranium, taking care to avoid dural sinus injury. A cruciate dural incision is performed to access the brain parenchyma, often with a small cortisectomy to create a pathway. The ventricular , primed with saline and equipped with a stylet, is inserted perpendicular to the skull surface at a depth of 5-7 cm, directed toward the medial of the ipsilateral eye and 1-2 cm anterior to the tragus to reach the foramen of Monro; if initial passage fails, the trajectory may be adjusted slightly medially on a second attempt. Once ventricular entry is suspected, the stylet is removed to check for (CSF) backflow, and the is advanced an additional 1-2 cm if flow is confirmed. The is then tunneled subcutaneously for 3-4 cm, secured with non-absorbable sutures at the exit , and connected to a closed drainage system via a three-way stopcock. Guidance during insertion is most commonly freehand, utilizing anatomical landmarks, which carries a misplacement of 10-40% depending on ventricular size and , with accuracy rates around 70-83% for optimal positioning in the frontal horn. In cases of distorted anatomy, such as small or shifted ventricles, advanced methods improve precision: provides real-time visualization for trajectory adjustment, stereotaxy or neuronavigation offers preoperative planning and intraoperative tracking to reduce passes needed, allows direct ventricular visualization, and emerging technologies such as systems (e.g., using ) have shown promise in further enhancing precision as of 2025. Intraoperative confirmation of correct placement relies primarily on immediate CSF return upon stylet withdrawal, indicating ventricular puncture, followed by transduction of opening () through the connected system to verify functionality. If flow is absent or questionable, or portable may be used for real-time imaging to assess tip position, though postoperative remains the gold standard for final verification.

Postoperative Management

Monitoring and Care

Following placement of an external ventricular drain (EVD), continuous () monitoring is essential to guide management and prevent secondary brain injury. The transducer is zeroed at the level of the Foramen of Monro, approximated by the external auditory meatus in the patient, using a leveling such as a Carpenter's level or to ensure accurate readings. ICP waveforms are interpreted to assess compliance: normal patterns feature three peaks (P1 as the sharpest percussion wave, P2 reflecting intracranial compliance, and P3 as the dicrotic notch), while elevated P2 amplitude or loss of pulsatility may indicate rising ICP or dysfunction. The target ICP is typically maintained below 20-25 mmHg, with drainage initiated if thresholds are exceeded for more than 5 minutes. Drainage management involves adjusting the height of the collection system, often set at 10-20 cm H₂O above the external auditory meatus to control (CSF) outflow and avoid over- or under-drainage. Common modes include continuous drainage (e.g., at 10 mL/hour), intermittent drainage (opened for symptoms or elevated ), or ICP-triggered release, selected based on the underlying pathology such as or . Daily CSF output is tracked, with typical drained volumes ranging from 100-300 mL per day in many patients; excessive output (>20 mL/hour) prompts evaluation for overdrainage, while minimal output suggests possible obstruction. Nursing protocols emphasize prevention and system integrity through sterile changes at the insertion site every 48-72 hours or if soiled, using aseptic technique to minimize risk. CSF sampling for cell count, glucose, and culture is limited to fewer than three times per week, performed via the proximal port with slow (≤1 mL/min) and strict sterility to avoid . If is suspected, gentle with less than 2 mL of sterile saline may be attempted under guidance, but only if is stable. Patient care focuses on positioning and activity to optimize ICP control, including head elevation to 30 degrees to promote venous outflow while maintaining EVD height. Valsalva maneuvers, such as straining or coughing, are avoided by using stool softeners and suctioning as needed to prevent acute ICP spikes. Signs of EVD dysfunction, including absent drainage, suddenly rising ICP, or altered waveform, require immediate notification of the neurosurgical team for troubleshooting.

Weaning and Removal

The weaning process for an external ventricular drain (EVD) involves systematically reducing () drainage to assess the patient's ability to maintain normal () without ongoing intervention, typically once the underlying condition has stabilized. Two primary strategies are employed: gradual weaning and rapid closure. In gradual weaning, the drainage height is incrementally raised by 5 every 24 hours until reaching 20-25 H₂O, followed by a clamping trial of 24-48 hours, during which , neurological status, and symptoms such as are closely to ensure stability. Alternatively, rapid closure entails immediate clamping of the EVD for 24 hours, with for any signs of or elevation exceeding 20 mmHg for more than 5 minutes; this approach may shorten hospital length of stay but carries a higher risk of failure in some cohorts. During these trials, parameters such as trends and clinical examination, as established in routine postoperative , guide decisions to proceed or reopen drainage. Removal criteria emphasize sustained stability to minimize risks of recurrence. The EVD is considered for removal when remains below 15-20 mmHg for 24-48 hours, daily CSF output is less than 250 mL, CSF is non-bloody, the is stable (e.g., no deterioration in ), and imaging confirms resolution of without ventricular enlargement. Additionally, the underlying , such as or , must be resolving, with no active present; coagulopathy should be corrected prior to discontinuation. Failure of weaning trials, indicated by rise, clinical worsening, or new on computed (), necessitates reopening the drain or alternative interventions. The removal technique is typically performed at the bedside by a neurosurgeon or trained provider under sterile conditions to reduce risk. Sutures securing the are cut, and the device is gently withdrawn in a straight trajectory while applying countertraction to the skin to prevent tract disruption; the incision is then closed with sutures or staples. Immediately following removal, a head is obtained to evaluate for hemorrhage or ventricular changes, ensuring early detection of any adverse effects. If chronic CSF diversion is required after EVD removal, transition to a permanent ventriculoperitoneal (VP) shunt may be indicated for ongoing management, with placement often delayed until infection is ruled out. In select cases, a temporary drain can serve as a bridge during this period, allowing further assessment of CSF dynamics before committing to a shunt. These transitions are individualized based on imaging and clinical response to weaning.

Complications

Hemorrhagic Complications

Hemorrhagic complications associated with external ventricular drains (EVDs) primarily include along the catheter tract, subdural or epidural hematomas, and intraventricular bleeding. , often resulting from vessel puncture during insertion, occurs in 10-34% of cases, though clinically significant events are less frequent at approximately 5-10%. Subdural and epidural hematomas may arise from catheter migration or overdrainage, with reported incidences varying from 1-5% in retrospective series. Intraventricular bleeding is rarer but can occur if subependymal vessels are disrupted, contributing to overall hemorrhage rates of up to 33% when including minor events detected on routine imaging. Key risk factors for these hemorrhagic events encompass , such as (platelet count <100,000/μL) or elevated INR (>1.5), uncontrolled , and procedural elements like multiple catheter passes during insertion. Patients with underlying or exhibit higher rates, up to 39%, compared to other cohorts. Additionally, EVD removal carries a separate risk of hemorrhage in 7.8-22.5% of cases, often due to tract disruption. Diagnosis typically involves serial computed (CT) scans immediately post-insertion and at 24-48 hours, or sooner if neurological deterioration occurs, to identify new hemorrhages and assess for or progression. Management strategies depend on hemorrhage size and symptoms: minor tract bleeds often require only observation and supportive care, while is addressed with reversal agents such as (FFP) for INR correction or platelet transfusions. Significant hematomas causing or necessitate urgent surgical evacuation, potentially via , alongside temporary cessation of drainage if feasible. Prevention focuses on preoperative optimization of parameters, aiming for platelet counts >100,000/μL and INR <1.5, and controlling to systolic levels below 160 mmHg. Image-guided techniques, such as frameless stereotaxy or , reduce risk by minimizing blind passes, with studies showing lower hemorrhage rates compared to freehand methods. Limiting insertion attempts to one or two and selecting optimal trajectories further mitigates risks during placement.

Infectious Complications

Infectious complications associated with external ventricular drains (EVDs) primarily manifest as or , with reported incidence rates ranging from 2% to 36%, and a of approximately 11% across multiple studies. These infections are often caused by gram-positive organisms, particularly coagulase-negative staphylococci such as and , though gram-negative bacilli like and fungi such as species can also occur. The risk increases with prolonged EVD duration exceeding 5-7 days, (CSF) leaks, frequent CSF sampling or catheter manipulation, and use of non-antimicrobial-impregnated catheters. Additional factors include , prior systemic infections, and bilateral EVD placement. Diagnosis relies on a combination of clinical signs and laboratory findings from CSF obtained via the EVD. Common clinical indicators include new-onset fever, meningismus, and worsening neurological status, while CSF typically shows pleocytosis with counts greater than 10 cells/mm³, glucose levels below 40 mg/dL, elevated protein, and positive microbial cultures confirming the . Cultures should be held for at least 10 days to detect slow-growing organisms like Propionibacterium acnes, and supportive tests such as CSF may aid in cases with equivocal findings. Management involves prompt EVD removal to eliminate the nidus of , particularly in cases involving biofilms, followed by temporary if ongoing drainage is needed. Empiric intravenous antibiotics, such as combined with an anti-pseudomonal (e.g., cefepime or ), are initiated, targeting trough levels of 15-20 μg/mL, with therapy tailored to culture susceptibilities and continued for 10-14 days or up to 21 days for gram-negative . Intraventricular administration of antibiotics like (5-20 mg daily) may be considered for severe or cases, with the drain clamped briefly post-infusion. Prevention strategies emphasize antimicrobial-impregnated EVD catheters, which reduce risk by approximately 40-50% compared to standard catheters, alongside strict adherence to sterile insertion and handling protocols, care bundles from the Neurocritical Care Society, and minimizing EVD duration through early weaning when clinically feasible. Periprocedural systemic antibiotics are recommended to further mitigate initial colonization risks.

Mechanical Complications

Mechanical complications of external ventricular drains (EVDs) encompass hardware-related failures that disrupt (CSF) drainage or accurate () monitoring, potentially leading to inadequate management or elevated . The most prevalent types include obstruction, migration or malposition, and disconnection or kinking of the external tubing system. Obstruction, reported in 19-47% of cases, typically arises from clots, cellular , or fragments accumulating within the , compromising patency and necessitating to prevent acute neurological deterioration. Migration or malposition occurs in approximately 7-17% of insertions, often resulting from patient movement or inadequate initial securing, which positions the tip outside the ventricular space and impairs CSF outflow. Disconnection or kinking of the tubing, though less quantified, can stem from stress or improper assembly, further hindering system functionality. Diagnosis of these complications relies on clinical signs such as absence or reduction of CSF drip from the drainage chamber, lack of pulsatile CSF meniscus, or fluctuating and dampened waveforms on monitoring devices, indicating potential blockage or misalignment. If initial fails to restore flow, confirmatory via computed (CT) or plain head is essential to assess position relative to the ventricles, with CT preferred for its superior visualization of tip placement and any associated shifts. These diagnostic steps allow for prompt differentiation from other issues, ensuring targeted resolution without unnecessary procedures. Management prioritizes minimally invasive corrections to restore function rapidly. For suspected obstruction, gentle irrigation with 0.5-2 mL of preservative-free sterile normal saline can dislodge , performed cautiously by trained personnel to avoid over-pressurization. or malposition may require bedside repositioning under sterile conditions or surgical adjustment, while kinking or disconnection involves straightening the tubing, reconnecting components, or verifying the drainage height relative to the external auditory to optimize gravitational flow. Persistent failures, such as no output after 24 hours of troubleshooting, warrant complete EVD replacement to mitigate risks of prolonged underdrainage. Prevention of mechanical complications emphasizes meticulous technique and ongoing vigilance. Secure fixation using bolted or tunneled EVD systems reduces and dislodgement rates compared to traditional methods, with suturing or dressings applied immediately post-insertion to stabilize the . Regular patency assessments, including hourly checks of CSF output and trends, enable early detection of issues, while incorporating filtered drainage systems like the LiquoGuard device minimizes debris ingress and maintains consistent flow. These strategies, when combined with staff education on proper handling, significantly lower the overall incidence of hardware failures.

Neurological Complications

Neurological complications associated with external ventricular drain (EVD) placement primarily involve alterations in brain function due to pressure imbalances or direct tissue disruption, excluding hemorrhagic and infectious etiologies. These include , seizures, and focal neurological deficits, which can significantly impact patient outcomes if not promptly identified and addressed. may result from rapid overdrainage, which creates excessive negative gradients, or from malposition of the EVD catheter, potentially causing transtentorial or upward herniation syndromes. In patients with obstructive from posterior fossa lesions, upward herniation has been observed post-ventriculostomy, emphasizing the need for cautious (CSF) drainage to mitigate this risk. Seizures may occur following EVD insertion, often due to cortical irritation along the catheter tract or exacerbation of underlying brain pathology. Focal neurological deficits, such as or hemichorea-hemiballismus, can arise from malpositioned catheters causing direct neuronal injury, as evidenced by lesions along the EVD tract on imaging. Key risk factors for these complications include overdrainage, such as setting the drainage system too low, which can lead to formation through excessive CSF removal and brain sagging. Pre-existing further heightens vulnerability by altering intracranial compliance, making the brain more susceptible to pressure shifts during EVD use. Overdrainage may also contribute to development, as explored in the context of hemorrhagic complications. Diagnosis relies on vigilant monitoring of clinical neurological changes, including altered mental status, pupillary abnormalities, or motor asymmetries indicative of herniation. (EEG) is essential for detecting subclinical seizures, particularly in comatose patients where clinical signs may be obscured. Serial neurological examinations and imaging, such as computed tomography (CT), help confirm malposition or evolving deficits by visualizing catheter trajectory and brain shift. Management focuses on reversing the underlying mechanism while supporting neurological stability. Slow weaning of the EVD, typically by incremental height adjustments, prevents rebound elevation that could worsen herniation. For seizures, prompt initiation of anticonvulsants such as is recommended, given its efficacy in controlling post-procedural and traumatic seizures with a favorable safety profile. Suspected herniation due to malposition necessitates urgent repositioning or replacement under guidance to restore proper and alleviate gradients. Prevention strategies emphasize controlled CSF drainage rates, generally limited to 15-20 mL per hour to avoid excessive , combined with regular leveling of the drain at the patient's external auditory canal or mid-tragus. Frequent neurological checks, at least every 1-2 hours initially, enable early detection of subtle changes, allowing timely interventions to avert progression to severe deficits.

References

  1. [1]
    External ventricular drain - Mayo Clinic
    Sep 18, 2025 · During EVD placement, there's a small risk of bleeding in the brain along the path of the catheter. EVD blockage. Blood clots or tissue may clog ...Missing: definition | Show results with:definition
  2. [2]
    External Ventricular Drainage: A Practical Guide for Neuro ... - NIH
    Jan 31, 2023 · In the management of EVD in SAH, the intermittent drainage strategy is burdened with an elevated risk of complications (e.g., clogged catheter, ...
  3. [3]
    External ventricular drains: Management and complications - PMC
    Despite appropriate maintenance and surveillance of an EVD, complications such as obstruction and infection may arise given the invasive nature of the device.
  4. [4]
    Ventricular Drain - an overview | ScienceDirect Topics
    Continuous external ventricular drainage has been undertaken since the beginning of the twentieth century ... of an external ventricular drain is often considered ...
  5. [5]
    The Evolution of the Role of External Ventricular Drainage in ...
    Sep 10, 2019 · The procedure of external ventricular drainage was first reported in the 18th century to treat congenital hydrocephalus (Figure 1). Claude- ...
  6. [6]
    Ventriculostomy - StatPearls - NCBI Bookshelf - NIH
    Ventriculitis (20%)Infection is the most common complication of external ventricular drainage (EVD), with rates ranging from 0 to 45%. Technical failure ( ...Introduction · Technique or Treatment · Complications · Clinical Significance<|control11|><|separator|>
  7. [7]
    [PDF] Guidelines From the Society for Neurosci - SNACC
    These evidence-based guidelines aim to provide recommendations related to EVD and LD regarding (1) common indications, contraindications, complications, and ...
  8. [8]
    2022 Guideline for the Management of Patients With Spontaneous ...
    May 17, 2022 · This guideline recommends development of regional systems that provide initial intracerebral hemorrhage (ICH) care and the capacity, when appropriate, for ...<|control11|><|separator|>
  9. [9]
    Placement of an External Ventricular Drain
    Jan 13, 2021 · EVD placement should be avoided in patients who are taking anticoagulant or antiplatelet medications and in those with coagulopathy (i.e., a ...
  10. [10]
    [PDF] Perioperative Management of Adult Patients with External ... - SNACC
    Oct 8, 2016 · The document generated targets clinicians involved in perioperative care of patients with indwelling external ventricular and lumbar drains.
  11. [11]
    None
    Summary of each segment:
  12. [12]
    Perioperative Anticoagulation Management - StatPearls - NCBI - NIH
    Discontinue warfarin 5 days before surgery. Three days before surgery, start subcutaneous LMWH or unfractionated heparin (UFH) at therapeutic doses, depending ...
  13. [13]
    Surface anatomy for implantation of external ventricular drainage
    Aug 29, 2016 · The procedure consists of implementing a shunt in the right frontal horn of the lateral ventricle. It is usually done without any image guidance ...<|control11|><|separator|>
  14. [14]
    None
    ### Step-by-Step Procedure for External Ventricular Drain Placement
  15. [15]
    Freehand Insertion of External Ventricular Drainage Catheter - NIH
    Feb 25, 2020 · Freehand frontal EVD insertion is a safe procedure in terms of accuracy of position. The placement accuracy is at 83.1% with marginal complications.
  16. [16]
    The accuracy and safety of intraoperative ultrasound-guided ...
    Jul 17, 2023 · The incidence of complications and misplacement of EVD is up to 40% when performed freehand, showing the need for major improvements. The ...<|separator|>
  17. [17]
    Rapid versus gradual external ventricular drain weaning
    Apr 9, 2024 · Gradual weaning involves incrementally raising the drain height by 5 cm every 24 hours until it reaches a final level of 25 cm H2O, with the ...Missing: criteria | Show results with:criteria
  18. [18]
    Standardized Criteria to Initiate External Ventricular Drain (EVD ...
    Apr 16, 2024 · This study shares criteria used to initiate EVD weaning that displayed increased safety of EVD discontinuation for patients with subarachnoid hemorrhage ...
  19. [19]
    Management of external ventricular drain: to wean or not to wean?
    Jul 2, 2024 · One strategy is rapid closure, in which the EVD is immediately clamped and if no hydrocephalus symptoms occur removed on the following day, ...
  20. [20]
    Weaning from external ventricular drainage after non-traumatic ...
    Usually, the weaning process includes a 24−48 h EVD closure trial: in the absence of neurological deterioration, intracranial pressure rise or hydrocephalus on ...
  21. [21]
    [PDF] External Ventricular Drains: An Overview of Indications, Technique ...
    Jun 30, 2020 · External ventricular drains (EVDs or ventriculostomies) are frequently required for acute management of intracranial hyper-.
  22. [22]
    The Incidence of Catheter Tract Hemorrhage and ... - PubMed Central
    Incidence of catheter tract hemorrhage (CTH) after initial ventriculostomy placement ranges from 10 to 34%.
  23. [23]
    Risk factors for hemorrhage associated with external ventricular ...
    Hemorrhage is a common complication of EVD placement and occurs more frequently than originally believed. There is also risk of hemorrhage with removal of an ...
  24. [24]
    Risk factors for hemorrhage associated with external ventricular ...
    Apr 1, 2016 · Consequently, the incidence of hemorrhage following EVD placement has been shown to be much higher compared with historical reports.CONCLUSIONS · Methods · Results · Discussion<|control11|><|separator|>
  25. [25]
    Predictors of tract hemorrhage after external ventricular drain ...
    Nov 13, 2024 · Tract hemorrhage, in particular, is a common and potentially life-threatening complication that occurs in up to 7% of cases. The factors that ...
  26. [26]
    Hemorrhagic complications after removal of an external ventricular ...
    Aug 25, 2023 · Conclusion: Removal of an EVD is a safe procedure, with rare cases of hemorrhagic complications being reported. A case of a large hematoma that ...
  27. [27]
    Intracerebral hemorrhage after external ventricular drain placement
    Mar 7, 2018 · The reported rates of secondary hemorrhage after the placement of an EVD vary significantly with documented rates being as high as 41% [3].
  28. [28]
    Hemorrhagic Complications Associated with External Ventricular ...
    Jun 26, 2025 · At the same time, minor hemorrhages are common, though rare, and significant bleeding can cause ventriculitis.
  29. [29]
    Risk Factors for External Ventricular Drainage–Related Infection - NIH
    The incidence of EVD-related infections, including meningitis and ventriculitis, varies from <5% to 20% depending on the criteria of diagnosis.
  30. [30]
    Healthcare-Associated Ventriculitis and Meningitis - IDSA
    Feb 14, 2017 · New fever and increased CSF white blood cell count in patients with external ventricular drains could be suggestive of infection (weak, low).
  31. [31]
    2017 Infectious Diseases Society of America's Clinical Practice ...
    Feb 14, 2017 · In patients with healthcare-associated ventriculitis and meningitis and an external drainage device, monitoring of CSF cultures is recommended ...
  32. [32]
    The burden and risk factors of ventriculostomy occlusion in a high ...
    Oct 30, 2015 · The incidence of occlusion documented in this study falls within the range of previous studies that suggested nonpatent EVD in 19% to 47% of ...
  33. [33]
  34. [34]
    Ventriculostomy and Risk of Upward Herniation in Patients with ...
    The aim of our study was to evaluate for clinically relevant upward herniation following external ventricular drainage (EVD) in patients with obstructive ...
  35. [35]
    Hemichorea-Hemiballism after External Ventricular Drainage - PMC
    Sep 30, 2019 · The EVD malposition resulted in direct neuronal injury with hemichorea hemiballismus, as suggested by the lesions along the EVD tract. A ...<|control11|><|separator|>
  36. [36]
    External Ventricular Drain (EVD) & Lumbar drain - EMCrit Project
    Jun 22, 2022 · The EVD will be set to drain CSF when the CSF pressure exceeds a certain value equal to the height of the drainage apparatus (e.g., 5-15 cm H2O) ...
  37. [37]
    Electrographic seizures and periodic discharges after intracerebral ...
    In our study 19% of patients with ICH had clinical seizures preceding cEEG which is at the higher end of the previously reported frequency of 2.8% to 18.7%.
  38. [38]
    Levetiracetam - StatPearls - NCBI Bookshelf - NIH
    Levetiracetam is a novel antiepileptic drug used to treat partial, myoclonic, and tonic-clonic seizures.